2021 Scientific Sessions

Is TTVR the Future of Tricuspid Valve Therapy?

Presenter

James B. Hermiller, M.D., MSCAI, The St. Vincent Medical Group at The Heart Center, Indianapolis, IN
James B. Hermiller, M.D., MSCAI, The St. Vincent Medical Group at The Heart Center, Indianapolis, IN

Learning Objectives:
  1. Discuss transcatheter tricuspid valve replacement technologies and current advancements.
  2. Recognize where percutaneous tricuspid valve repair may fall short and potential role of TTVR.
  3. Describe early feasibility and upcoming/ongoing trials.
Keywords: Structural Heart Disease (SHD) and TTVR/Tricuspid Valve